Literature DB >> 3891269

Absorption of subcutaneously infused insulin: influence of the basal rate pulse interval.

P Hildebrandt, K Birch, B M Jensen, C Kühl, J Brange.   

Abstract

Eight insulin-dependent diabetic patients were given two constant infusions (each 1 IU/h) of 125I-labeled insulin into the abdominal subcutaneous tissue for about 12 h. Insulin was infused in pulses into one side of the abdomen in 6-min intervals (by means of an Auto-Syringe pump) and in the other side of the abdomen, insulin was infused in 1-h intervals (by means of a Medix pump). The size of the subcutaneous depots was continuously measured by counting the radioactivity at the infusion sites. After starting the infusions, the two depots were built up to steady-state levels at the same time and of the same size (approximately 3 IU) and with similar absorption rates. Thus, during basal rate insulin infusion, identical insulin absorption kinetics was achieved, irrespective of a 10-fold difference in the pulse rate.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891269     DOI: 10.2337/diacare.8.3.287

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  4 in total

1.  Modeling absorption kinetics of subcutaneous injected soluble insulin.

Authors:  E Mosekilde; K S Jensen; C Binder; S Pramming; B Thorsteinsson
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

2.  Effects of pulsatile subcutaneous injections of insulin lispro on plasma insulin concentration levels.

Authors:  Alice Chan; Marc D Breton; Boris P Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2008-09

3.  Changes in basal insulin infusion rates with subcutaneous insulin infusion: time until a change in metabolic effect is induced in patients with type 1 diabetes.

Authors:  Lutz Heinemann; Leszek Nosek; Christoph Kapitza; Matthias-Axel Schweitzer; Lars Krinelke
Journal:  Diabetes Care       Date:  2009-06-01       Impact factor: 19.112

4.  Multi-Timescale Rhythmicity of Blood Glucose and Insulin Delivery Reveals Key Advantages of Hybrid Closed Loop Therapy.

Authors:  Azure D Grant; Dana M Lewis; Lance J Kriegsfeld
Journal:  J Diabetes Sci Technol       Date:  2021-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.